On February 17, 2023, THELMA Therapeutics Co., Ltd. closed the transaction. The company amended the terms of the transaction. The company issued 14,600,020 common shares at an issue price of KRW 700 per share for gross proceeds of 10,220,014,000.

The transaction included participation from KSR&R Co., Ltd. for 8,571,428 shares, The Snowball Co., Ltd. for 714,285 shares, returning investor, AirQ Holdings Inc. for 3,171,451 shares, along with individual investors, Sungyong Choi for 1,428,571 shares and Oh-taek Kwon for 714,285 shares.